Showing 221 - 240 results of 2,033 for search '"Pharmacoeconomics"', query time: 0.12s Refine Results
  1. 221

    Pharmacoeconomic analysis of flexible-dose administration regimen of Xeomine® in patients with focal dystonia by A. E. Cheberda, D. Yu. Belousov, S. K. Zyryanov

    Published 2018-06-01
    “…Use of incobotulinumtoxin А in a ­flexible-dose regimen is pharmacoeconomically justied.…”
    Get full text
    Article
  2. 222
  3. 223

    Pharmacoeconomic comparison of insulin glargine and insulin detemir in diabetes mellitus type 2 by I. N. Dyakov, S. K. Zyryanov

    Published 2020-09-01
    “…Second generation insulin analogue — insulin glargine 300 UI/ml (GLA-300) — can provide an effective control of Diabetes Mellitus (DM) with minimal risk of hypoglycemic events and prevent of cardiovascular complications or events (CVS). Pharmacoeconomic comparison of most used insulins — GLA-300 and detemir (IDet) has been based on indirect treatment comparison in DM Type 2. …”
    Get full text
    Article
  4. 224

    Pharmacoeconomics of dapagliflozin in patients with type 2 diabetes mellitus with inadequate glycemic control by S. K. Zyryanov, M. F. Kalashnikova, D. Yu., E. V. Afanasyeva

    Published 2018-06-01
    “…The results are expressed in QALY and ICUR. Pharmacoeconomic analysis showed that the application of the strategy of treatment: metformin + dapagliflozin vs metformin + sitagliptin provided 9.83 and 9.82 QALYs respectively, and the ICUR — 341.413 rubles; metformin + dapagliflozin vs metformin + glimepiride provided 9.82 and 9.47 QALY respectively, and the ICUR — 145.213 rubles. …”
    Get full text
    Article
  5. 225
  6. 226

    PRELIMINARY RESULTS OF COMPARATIVE PHARMACOECONOMIC PROSPECTIVE STUDY OF DIFFERENT THERAPIES OF ARTERIAL HYPERTENSION by E. I. Tarlovskaya, N. S. Maksimchuk, S. V. Malchikova, M. V. Avksentieva

    Published 2015-12-01
    “…To carry out a comparative pharmacoeconomic analysis of two different types of antihypertensive therapy in patients with arterial hypertension (HT). …”
    Get full text
    Article
  7. 227
  8. 228
  9. 229
  10. 230
  11. 231

    New rules for the generic drugs market introduced by the "Decreto Abruzzi" by Mario Eandi

    Published 2009-03-01
    Subjects: “…pharmacoeconomics…”
    Get full text
    Article
  12. 232
  13. 233
  14. 234
  15. 235
  16. 236
  17. 237
  18. 238
  19. 239
  20. 240